And 8 hours later… –
April 26, 2019 – Psychedelic therapy holds a great deal of promise for treating some very serious mental health conditions and may one day offer new hope to vulnerable people with limited treatment options. Dr Robin Carhart-Harris … Psychedelics are set to have a major impact on neuroscience and psychiatry in the coming years. It’s such a privilege to be at the forefront of one of the most exciting areas in medical science. I am immensely grateful to the donors who have made all of this possible.”
Dr Carhart-Harris adds: “It may take a few years for psychedelic therapy to be available for patients, but research so far has been very encouraging. Early stage clinical research has shown that when delivered safely and professionally, psychedelic therapy holds a great deal of promise for treating some very serious mental health conditions and may one day offer new hope to vulnerable people with limited treatment options.”
Pioneering research
In the last decade a number of research groups in Europe and the Americas have conducted studies into the safety and effectiveness of psychedelics for conditions such as depression and post-traumatic stress disorder (PTSD), but the new Imperial centre is the first to gain this level of stature within a major academic institution.
